Deep learning model rivals radiologists in detecting prostate cancer on MRI

Researchers assess the power of a fully automated deep learning model to identify of clinically significant prostate cancer.

FDA declines to approve Zealand hypoglycaemia therapy in infants

The company had sought approval for dasiglucagon for the treatment and prevention of hypoglycaemia in infants with congenital hyperinsulinism. Credit: Gorodenkoff/Shutterstock. The US Food and

October 9, 2024

Hospitals, labs, and health departments try to cope with blood culture bottle shortage

Hospitals across the country are facing a severe shortage of supplies of blood culture bottles, critical tools for diagnosing serious and sometimes life-threatening bloodstream infections.

July 23, 2024

Merck ends two Phase 3 studies of Keytruda, including an early-stage non-small cell lung cancer trial

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.